These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 23418366)
21. Obstacles to the universal application of INNs. Prescrire Int; 2014 Oct; 23(153):248-51. PubMed ID: 25964979 [TBL] [Abstract][Full Text] [Related]
22. Naming, labeling, and packaging of pharmaceuticals. Kenagy JW; Stein GC Am J Health Syst Pharm; 2001 Nov; 58(21):2033-41. PubMed ID: 11715825 [TBL] [Abstract][Full Text] [Related]
23. Evaluating pharmacists' views, knowledge, and perception regarding generic medicines in New Zealand. Babar ZU; Grover P; Stewart J; Hogg M; Short L; Seo HG; Rew A Res Social Adm Pharm; 2011 Sep; 7(3):294-305. PubMed ID: 21272551 [TBL] [Abstract][Full Text] [Related]
25. [Generic prescription should be evaluated as new way of prescription in Denmark]. Hellebek A; Søndergaaard J; Thirstrup S; Sales Y Ugeskr Laeger; 2012 Aug; 174(35):1974. PubMed ID: 22929572 [No Abstract] [Full Text] [Related]
26. Advertising and generic market entry. Königbauer I J Health Econ; 2007 Mar; 26(2):286-305. PubMed ID: 17011648 [TBL] [Abstract][Full Text] [Related]
27. Quality Use of Medicines--medication safety issues in naming; look-alike, sound-alike medicine names. Ostini R; Roughead EE; Kirkpatrick CM; Monteith GR; Tett SE Int J Pharm Pract; 2012 Dec; 20(6):349-57. PubMed ID: 23134093 [TBL] [Abstract][Full Text] [Related]
28. Automatic identification of confusable drug names. Kondrak G; Dorr B Artif Intell Med; 2006 Jan; 36(1):29-42. PubMed ID: 16359851 [TBL] [Abstract][Full Text] [Related]
29. Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia. McManus P; Birkett DJ; Dudley J; Stevens A Pharmacoepidemiol Drug Saf; 2001; 10(4):295-300. PubMed ID: 11760489 [TBL] [Abstract][Full Text] [Related]
30. Lyell syndrome and epileptic seizures after confusion between Lamictal and Lamisil. Prescrire Int; 2010 Aug; 19(108):169. PubMed ID: 20939451 [TBL] [Abstract][Full Text] [Related]
31. What's in a name? Lessening the confusion over drug names. Home Care Provid; 2000 Apr; 5(2):62-6. PubMed ID: 10835153 [TBL] [Abstract][Full Text] [Related]
32. Drugs and their names. Drug Ther Bull; 2018 Mar; 56(3):33-36. PubMed ID: 29545265 [TBL] [Abstract][Full Text] [Related]
33. Examining patterns in medication documentation of trade and generic names in an academic family practice training centre. Summers A; Ruderman C; Leung FH; Slater M BMC Med Educ; 2017 Sep; 17(1):175. PubMed ID: 28938883 [TBL] [Abstract][Full Text] [Related]
35. INN-based prescribing: a good practice not widely adopted in France. Prescrire Int; 2011; 20(118):191-2. PubMed ID: 21755621 [TBL] [Abstract][Full Text] [Related]
36. Generic medicine pricing in Europe: current issues and future perspective. Simoens S J Med Econ; 2008; 11(1):171-5. PubMed ID: 19450118 [TBL] [Abstract][Full Text] [Related]
37. [Defining generic drugs: an end or a means? Analysis of regulations in 14 countries in the Region of the Americas]. Vacca González CP; Fitzgerald JF; Bermúdez JA Rev Panam Salud Publica; 2006 Nov; 20(5):314-23. PubMed ID: 17316489 [TBL] [Abstract][Full Text] [Related]
38. The Impact of International Nonproprietary Names Integration on Prescribing Reimbursement Medicines for Arterial Hypertension and Analysis of Medication Errors in Latvia. Gavrilova A; Zolovs M; Latkovskis G; Urtāne I Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011791 [TBL] [Abstract][Full Text] [Related]